4//SEC Filing
KABAKOFF DAVID S 4
Accession 0001447362-21-000070
CIK 0001447362other
Filed
Apr 6, 8:00 PM ET
Accepted
Apr 7, 6:15 PM ET
Size
10.3 KB
Accession
0001447362-21-000070
Insider Transaction Report
Form 4
KABAKOFF DAVID S
Director10% Owner
Transactions
- Sale
Common Stock
2021-04-05$71.79/sh−50,000$3,589,600→ 593,577 total(indirect: By L.P.) - Sale
Common Stock
2021-04-05$73.22/sh−20,000$1,464,422→ 573,577 total(indirect: By L.P.) - Sale
Common Stock
2021-04-06$73.99/sh−40,000$2,959,708→ 533,577 total(indirect: By L.P.)
Footnotes (5)
- [F1]The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by Sofinnova HealthQuest Partners, L.P. on December 17, 2020.
- [F2]This transaction was executed in multiple trades at prices ranging from $71.1820 to $72.1647, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]Held by Sofinnova HealthQuest Partners, L.P., or HealthQuest Partners. HealthQuest Venture Management, L.L.C., or HealthQuest Management, is the general partner of HealthQuest Partners. David Kabakoff, Ph.D., the Reporting Person, is a partner of HealthQuest Management. Garheng Kong is the managing member of HealthQuest Management and has sole voting and investment power over the shares held by HealthQuest Partners. Each of HealthQuest Management, Mr. Kong and Dr. Kabakoff disclaims beneficial ownership over all shares held by HealthQuest Partners except to the extent of any pecuniary interest therein.
- [F4]This transaction was executed in multiple trades at prices ranging from $73.1857 to $73.2564, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F5]This transaction was executed in multiple trades at prices ranging from $73.4821 to $74.1945, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
CASTLE BIOSCIENCES INC
CIK 0001447362
Entity typeother
IncorporatedCA
Related Parties
1- filerCIK 0001024008
Filing Metadata
- Form type
- 4
- Filed
- Apr 6, 8:00 PM ET
- Accepted
- Apr 7, 6:15 PM ET
- Size
- 10.3 KB